lthH

eas

of

Technical Assistance Programs:Technical Assistance Programs:Ni h & CAPtu

tes

Niche & CAPMay 30-31, 2012 – Louisville, KYns

tit

y , ,14th Annual NIH SBIR/STTR Conference

nal I

n

Robert VinsonSBIR/STTR Assistant Program Manager

Office of Extramural Researchatio

n

11

Office of Extramural ResearchNa

NIH Mission

Improve human health th h bi di l dthrough biomedical and

behavioral research, h t i i dresearch training and

communications.

22

SBIR/STTR Programs/ g

C it l i i th f f t d t tCapital is in the form of grants and contracts;strategic NIH Investment in Innovationg

fNon-diluted funding:• no repaymentno repayment• no debt service• no equity forfeiture• no IP forfeiture

33

no IP forfeiture

NIH Institute/Center SBIR/STTR Budget Allocations (FY2012)Budget Allocations (FY2012)

FY 2012 SBIR/STTRFY 2012 SBIR/STTR Budget Allocations to NIH ICs:

$632 M (SBIR)$632 M (SBIR)$ 85 M (STTR)

Total: $717 MTotal: $717 M

Extramural R&D Set-Asides:SBIR = 2.60%STTR = 0 35%

44

STTR = 0.35%NIGMSNIDDK

Innovative Approaches to Commercialization Challengesto Commercialization Challenges

T h l Ni h A t

NIH Technical Assistance Programs

Mt. “FDA”???

Technology Niche Assessment

Commercialization Assistance Program

Phase I Phase II Phase III“Valley of Death”Valley of Death

55

Niche Assessment Program

Phase I SBIR awardees with current or soon to be awarded Phase I (Notice

Technology Niche Analysis ™awarded Phase I (Notice of Award)

• Identify other uses of technology

• Determines competitive advantages

• Market size and potential

B i t t & t t• Barriers to entry & strategy

• Feedback from potential end-users

66

Commercialization Assistance P (CAP)Program (CAP)

Phase II SBIR awardees

5 years since

Business Counseling, Training and Mentoring

completion of project

g

• Business & strategic planning

&• Investor & partnership pitch

• Technology Valuation

• FDA regulatory requirements

IP & Licensing Issues

77

• IP & Licensing Issues

The Impactp

• How do we measure SUCCESS?– Met with or closed deals with investors?– Had meetings with the FDA or was approved?– Achieved revenues; launched a product?p– Signed licensing agreements?– Hired new employees?p y– Established partnerships? Signed CDA?

• By the Numbers: 700 companies trained• By the Numbers: 700 companies trained- Almost $400 M raised in equity

10 M&A

88

- 10 M&A

http://grants.nih.gov/grants/funding/cap/index.htmp g g g g p

99

http://grants nih gov/grants/funding/sbir htmhttp://grants.nih.gov/grants/funding/sbir.htm

THANK YOU!THANK YOU!Robert Vinson

NIH SBIR/STTR Assistant Program ManagerAssistant Program Manager

Phone: 301-435-2713 Email: vinsonr@mail.nih.gov

OFFICE OF EXTRAMURAL PROGRAMS: SBIR/STTR